Results 151 to 160 of about 165,320 (303)
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant
ABSTRACT Graft versus host disease (GVHD) prophylaxis with posttransplant cyclophosphamide (ptCY) and cytomegalovirus (CMV) prophylaxis with letermovir have changed the clinical epidemiology of CMV infection. We studied the incidence, risk factors for, and outcomes of CMV infection after Day + 90 of allogeneic hematopoietic cell transplant (alloHCT ...
George L. Chen +15 more
wiley +1 more source
The Operation of Canada's Only Virtually Operated Radiation Oncology Service During the COVID-19 Pandemic. [PDF]
Romani C +7 more
europepmc +1 more source
The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
ABSTRACT Allogeneic hematopoietic cell transplantation (allo‐HCT) is an effective treatment for patients with high‐risk hematologic malignancies. Over the last decade, gut microbiota composition during allo‐HCT has been associated with patients' outcomes.
Wenjing Hao +4 more
wiley +1 more source
Purpose Identify factors influencing audiological care for chemotherapy‐induced ototoxicity from the perspectives of oncology providers in the Veterans Health Administration (VA), and quantify audiology service use among Veterans receiving ototoxic ...
Cecilia Lacey +9 more
doaj +1 more source
Integration of a patient-centred MUO/CUP service within a new acute oncology service: challenges and rewards. [PDF]
Dasgupta S +5 more
europepmc +1 more source
ABSTRACT Talquetamab is a GPRC5D × CD3 bispecific antibody approved for relapsed/refractory multiple myeloma (RRMM). This is the first real‐world study to comprehensively report muco‐cutaneous toxicities, infections, and efficacy of talquetamab in 151 patients across five countries with the longest follow‐up reported enabling better efficacy and ...
Murali Janakiram +94 more
wiley +1 more source
Use of telehealth and eHealth technologies in patient care by psycho-oncology service providers in low-middle-income countries during the COVID-19. [PDF]
Estapé T, Phillip EJ, Bergerot CD.
europepmc +1 more source
ABSTRACT Limited data exist on how patients and physicians perceive immune thrombocytopenia (ITP) symptoms and treatment‐related burden. I‐WISh (ITP World Impact Survey) 2.0 surveyed 1018 patients and 431 physicians in 15 countries to characterize the impact of ITP and its treatments on patients.
Nichola Cooper +17 more
wiley +1 more source
Top priorities for health service improvements among Australian oncology patients
Objective: To determine among a sample of Australian cancer patients receiving outpatient oncology care: 1) the most frequently endorsed general health service improvements selected by patients; 2) for the three most endorsed general health service ...
Robert Sanson-Fisher (21136211) +5 more
core
How to Build a Cardio-Oncology Service? [PDF]
Farmakis, D. +2 more
openaire +3 more sources

